Rapid-acting insulin analogs such as insulin aspart, insulin lispro and insulin gluligine are used to control postprandial hyperglycemia, although the use of prandial insulin results in a higher risk of hypoglycemia and weight gain compared with the use of basal insulin [128]. Here, INS is linked to Hyperglycemia.